These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33106877)

  • 21. Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer.
    Hu Y; Ding J; Wu C; Gao H; Ge M; Shao Q; Liu Y; Ye Q
    Front Oncol; 2022; 12():845765. PubMed ID: 35936748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of multi-omics differences in left-side and right-side colon cancer.
    Huang Y; Duanmu J; Liu Y; Yan M; Li T; Jiang Q
    PeerJ; 2021; 9():e11433. PubMed ID: 34026368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
    Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
    BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?
    Yu MM; Shi D; Li Q; Li JB; Li Q; Yu RS
    Jpn J Radiol; 2023 Jan; 41(1):83-91. PubMed ID: 35976561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
    BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological differences and correlations between right and left colon cancer.
    Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
    World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910.
    Shida D; Kuchiba A; Shibata T; Hamaguchi T; Yamasaki S; Ito M; Kobatake T; Tonooka T; Masaki T; Shiozawa M; Takii Y; Uetake H; Okamura S; Ojima H; Kazama S; Takeyama H; Kanato K; Shimada Y; Murakami Y; Kanemitsu Y
    Cancer Sci; 2023 Aug; 114(8):3352-3363. PubMed ID: 37189003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying important microbial and genomic biomarkers for differentiating right- versus left-sided colorectal cancer using random forest models.
    Kolisnik T; Sulit AK; Schmeier S; Frizelle F; Purcell R; Smith A; Silander O
    BMC Cancer; 2023 Jul; 23(1):647. PubMed ID: 37434131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.
    Chiu JW; Krzyzanowska MK; Serra S; Knox JJ; Dhani NC; Mackay H; Hedley D; Moore M; Liu G; Burkes RL; Brezden-Masley C; Roehrl MH; Craddock KJ; Tsao MS; Zhang T; Yu C; Kamel-Reid S; Siu LL; Bedard PL; Chen EX
    Clin Colorectal Cancer; 2018 Mar; 17(1):73-79. PubMed ID: 29128266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
    Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
    World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction.
    Li W; Qiu T; Guo L; Ying J; Zhou A
    Pathol Res Pract; 2019 Mar; 215(3):483-489. PubMed ID: 30611619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
    Jiang Y; Yan X; Liu K; Shi Y; Wang C; Hu J; Li Y; Wu Q; Xiang M; Zhao R
    BMC Cancer; 2020 Oct; 20(1):1012. PubMed ID: 33076847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis.
    Nitsche U; Stögbauer F; Späth C; Haller B; Wilhelm D; Friess H; Bader FG
    Dig Surg; 2016; 33(2):157-63. PubMed ID: 26824772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences Between Right and Left Colon Cancer in Beira Interior.
    Gonçalves C; Duarte L; Alves JJC
    Cureus; 2023 Apr; 15(4):e37500. PubMed ID: 37187661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.
    Chen J; Zhou L; Gao J; Lu T; Wang J; Wu H; Liang Z
    Front Oncol; 2020; 10():917. PubMed ID: 32582557
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location.
    Shi C; Ma J; Zhang T; Shi Y; Duan W; Huang D; Zhang H; Zeng Y
    BMC Med Genomics; 2023 Nov; 16(1):289. PubMed ID: 37974218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases.
    Wang HW; Yan XL; Wang LJ; Zhang MH; Yang CH; Wei-Liu ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Transl Med; 2021 Jul; 19(1):313. PubMed ID: 34281583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
    Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
    PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
    Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
    BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.